Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 527

1.

Pharmacokinetic properties of a novel inosine analog, 4'-cyano-2'-deoxyinosine, after oral administration in rats.

Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M.

PLoS One. 2018 Jun 6;13(6):e0198636. doi: 10.1371/journal.pone.0198636. eCollection 2018.

2.

Haemin-induced cell death in human monocytic cells is consistent with ferroptosis.

Imoto S, Kono M, Suzuki T, Shibuya Y, Sawamura T, Mizokoshi Y, Sawada H, Ohbuchi A, Saigo K.

Transfus Apher Sci. 2018 May 29. pii: S1473-0502(18)30224-6. doi: 10.1016/j.transci.2018.05.028. [Epub ahead of print]

PMID:
29859670
3.

Effects of long-term intake of a yogurt fermented with Lactobacillus delbrueckii subsp. bulgaricus 2038 and Streptococcus thermophilus 1131 on mice.

Usui Y, Kimura Y, Satoh T, Takemura N, Ouchi Y, Ohmiya H, Kobayashi K, Suzuki H, Koyama S, Hagiwara S, Tanaka H, Imoto S, Eberl G, Asami Y, Fujimoto K, Uematsu S.

Int Immunol. 2018 May 15. doi: 10.1093/intimm/dxy035. [Epub ahead of print]

PMID:
29767727
4.

Azacitidine effectively reduces TP53-mutant leukemic cell burden in secondary acute myeloid leukemia after cord blood transplantation.

Takei T, Yokoyama K, Shimizu E, Konuma T, Takahashi S, Yamaguchi R, Imoto S, Miyano S, Tojo A.

Leuk Lymphoma. 2018 Apr 12:1-2. doi: 10.1080/10428194.2018.1443335. [Epub ahead of print] No abstract available.

PMID:
29648492
5.

A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies.

Inoue D, Fujino T, Sheridan P, Zhang YZ, Nagase R, Horikawa S, Li Z, Matsui H, Kanai A, Saika M, Yamaguchi R, Kozuka-Hata H, Kawabata KC, Yokoyama A, Goyama S, Inaba T, Imoto S, Miyano S, Xu M, Yang FC, Oyama M, Kitamura T.

Leukemia. 2018 Jun;32(6):1327-1337. doi: 10.1038/s41375-018-0083-3. Epub 2018 Mar 3.

PMID:
29556021
6.

Pharmacokinetics studies of 4'-cyano-2'-deoxyguanosine, a potent inhibitor of the hepatitis B virus, in rats.

Hashimoto M, Taguchi K, Ishiguro T, Kohgo S, Imoto S, Yamasaki K, Mitsuya H, Otagiri M.

J Pharm Pharmacol. 2018 Jun;70(6):723-731. doi: 10.1111/jphp.12897. Epub 2018 Mar 12.

PMID:
29528116
7.

Aqueous TMAO solutions as seen by theoretical THz spectroscopy: hydrophilic versus hydrophobic water.

Imoto S, Forbert H, Marx D.

Phys Chem Chem Phys. 2018 Feb 28;20(9):6146-6158. doi: 10.1039/c7cp07003a.

PMID:
29457173
8.

Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.

VanderWeele DJ, Finney R, Katayama K, Gillard M, Paner G, Imoto S, Yamaguchi R, Wheeler D, Lack J, Cam M, Pontier A, Nguyen YTM, Maejima K, Sasaki-Oku A, Nakano K, Tanaka H, Vander Griend D, Kubo M, Ratain MJ, Miyano S, Nakagawa H.

Eur Urol Focus. 2018 Feb 1. pii: S2405-4569(18)30007-5. doi: 10.1016/j.euf.2018.01.006. [Epub ahead of print]

9.

Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology.

Fujita K, Chen X, Homma H, Tagawa K, Amano M, Saito A, Imoto S, Akatsu H, Hashizume Y, Kaibuchi K, Miyano S, Okazawa H.

Nat Commun. 2018 Jan 30;9(1):433. doi: 10.1038/s41467-018-02821-z.

10.

[Autologous peripheral blood stem cell transplantation for double-refractory myeloma with K-RAS and N-RAS mutations].

Jimbo K, Yokoyama K, Ogawa M, Hirano M, Ochi K, Kobayashi M, Yusa N, Shimizu E, Kawamata T, Yasui H, Ohno N, Yamaguchi R, Imoto S, Furukawa Y, Miyano S, Imai Y, Tojo A.

Rinsho Ketsueki. 2017;58(12):2380-2385. doi: 10.11406/rinketsu.58.2380. Japanese.

PMID:
29332870
11.

Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.

Ogawa M, Yokoyama K, Hirano M, Jimbo K, Ochi K, Kawamata T, Ohno N, Shimizu E, Yokoyama N, Yamaguchi R, Imoto S, Uchimaru K, Takahashi N, Miyano S, Imai Y, Tojo A.

Br J Haematol. 2017 Dec 19. doi: 10.1111/bjh.15065. [Epub ahead of print] No abstract available.

PMID:
29265350
12.

Characterization of the B-cell receptor repertoires in peanut allergic subjects undergoing oral immunotherapy.

Kiyotani K, Mai TH, Yamaguchi R, Yew PY, Kulis M, Orgel K, Imoto S, Miyano S, Burks AW, Nakamura Y.

J Hum Genet. 2018 Feb;63(2):239-248. doi: 10.1038/s10038-017-0364-0. Epub 2017 Nov 30.

PMID:
29192240
13.

Radiofrequency Ablation of Breast Cancer: A Retrospective Study.

Ito T, Oura S, Nagamine S, Takahashi M, Yamamoto N, Yamamichi N, Earashi M, Doihara H, Imoto S, Mitsuyama S, Akazawa K.

Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241-0. doi: 10.1016/j.clbc.2017.09.007. [Epub ahead of print]

14.

Adaptive NetworkProfiler for Identifying Cancer Characteristic-Specific Gene Regulatory Networks.

Park H, Shimamura T, Imoto S, Miyano S.

J Comput Biol. 2018 Feb;25(2):130-145. doi: 10.1089/cmb.2017.0120. Epub 2017 Oct 20.

PMID:
29053381
15.

Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2.

Seo K, Kim SK, Kim SR, Ohtani A, Kobayashi M, Kato A, Morimoto E, Saijo Y, Kim KI, Imoto S, Kim CW, Yano Y, Kudo M, Hayashi Y.

Dig Dis. 2017;35(6):541-547. doi: 10.1159/000480145. Epub 2017 Oct 17.

PMID:
29040986
16.

Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.

Imoto S, Kim SR, Amano K, Iio E, Yoon S, Hirohata S, Yano Y, Ishikawa T, Katsushima S, Komeda T, Fukunaga T, Chung H, Kokuryu H, Horie Y, Hatae T, Fujinami A, Kim SK, Kudo M, Tanaka Y.

Dig Dis. 2017;35(6):531-540. doi: 10.1159/000480143. Epub 2017 Oct 17.

PMID:
29040985
17.

Requirement of glycosylation machinery in TLR responses revealed by CRISPR/Cas9 screening.

Sato R, Shibata T, Tanaka Y, Kato C, Yamaguchi K, Furukawa Y, Shimizu E, Yamaguchi R, Imoto S, Miyano S, Miyake K.

Int Immunol. 2017 Aug 1;29(8):347-355. doi: 10.1093/intimm/dxx044.

PMID:
28992181
18.

Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutation.

Kobayashi M, Yokoyama K, Shimizu E, Yusa N, Ito M, Yamaguchi R, Imoto S, Miyano S, Tojo A.

Ann Hematol. 2018 Feb;97(2):367-369. doi: 10.1007/s00277-017-3134-3. Epub 2017 Sep 27. No abstract available.

PMID:
28956125
19.

Quantitative analysis of hemin-induced neutrophil extracellular trap formation and effects of hydrogen peroxide on this phenomenon.

Ohbuchi A, Kono M, Kitagawa K, Takenokuchi M, Imoto S, Saigo K.

Biochem Biophys Rep. 2017 Jul 24;11:147-153. doi: 10.1016/j.bbrep.2017.07.009. eCollection 2017 Sep.

20.

Identification of a p53-repressed gene module in breast cancer cells.

Miyamoto T, Tanikawa C, Yodsurang V, Zhang YZ, Imoto S, Yamaguchi R, Miyano S, Nakagawa H, Matsuda K.

Oncotarget. 2017 Jul 26;8(34):55821-55836. doi: 10.18632/oncotarget.19608. eCollection 2017 Aug 22.

21.

Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cells.

Tsuda Y, Tanikawa C, Miyamoto T, Hirata M, Yodsurang V, Zhang YZ, Imoto S, Yamaguchi R, Miyano S, Takayanagi H, Kawano H, Nakagawa H, Tanaka S, Matsuda K.

Sci Rep. 2017 Sep 6;7(1):10739. doi: 10.1038/s41598-017-11208-x.

22.

Identification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensors.

Fujii K, Miyahara Y, Harada N, Muraoka D, Komura M, Yamaguchi R, Yagita H, Nakamura J, Sugino S, Okumura S, Imoto S, Miyano S, Shiku H.

Oncoimmunology. 2017 Mar 20;6(5):e1306617. doi: 10.1080/2162402X.2017.1306617. eCollection 2017.

23.

A novel entecavir analogue constructing with a spiro[2.4]heptane core structure in the aglycon moiety: Its synthesis and evaluation for anti-hepatitis B virus activity.

Kumamoto H, Fukano M, Imoto S, Kohgo S, Odanaka Y, Amano M, Kuwata-Higashi N, Mitsuya H, Haraguchi K, Fukuhara K.

Nucleosides Nucleotides Nucleic Acids. 2017 Jul 3;36(7):463-473. doi: 10.1080/15257770.2017.1322209. Epub 2017 Jun 2.

PMID:
28574799
24.

The Transcriptional Landscape of p53 Signalling Pathway.

Tanikawa C, Zhang YZ, Yamamoto R, Tsuda Y, Tanaka M, Funauchi Y, Mori J, Imoto S, Yamaguchi R, Nakamura Y, Miyano S, Nakagawa H, Matsuda K.

EBioMedicine. 2017 Jun;20:109-119. doi: 10.1016/j.ebiom.2017.05.017. Epub 2017 May 18.

25.

Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.

Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N, Imoto S, Ichikawa D, Otsuji E, Miyano S, Kawano T, Inazawa J.

Oncotarget. 2017 Jun 6;8(23):37740-37750. doi: 10.18632/oncotarget.17147.

26.

OVarCall: Bayesian Mutation Calling Method Utilizing Overlapping Paired-End Reads.

Moriyama T, Shiraishi Y, Chiba K, Yamaguchi R, Imoto S, Miyano S.

IEEE Trans Nanobioscience. 2017 Mar 1. doi: 10.1109/TNB.2017.2670601. [Epub ahead of print]

PMID:
28278479
27.

Synthesis of native-like crosslinked duplex RNA and study of its properties.

Onizuka K, Hazemi ME, Thomas JM, Monteleone LR, Yamada K, Imoto S, Beal PA, Nagatsugi F.

Bioorg Med Chem. 2017 Apr 1;25(7):2191-2199. doi: 10.1016/j.bmc.2017.02.034. Epub 2017 Feb 21.

28.

Sequence-specific bias correction for RNA-seq data using recurrent neural networks.

Zhang YZ, Yamaguchi R, Imoto S, Miyano S.

BMC Genomics. 2017 Jan 25;18(Suppl 1):1044. doi: 10.1186/s12864-016-3262-5.

29.

Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

Kim SK, Kim SR, Imoto S, Kim CW, Hayashi Y.

Turk J Gastroenterol. 2017 Jan;28(1):75-76. doi: 10.5152/tjg.2016.0433. Epub 2016 Dec 23. No abstract available.

30.

Chronic adnexal torsion: An under-recognized disease entity.

Takeda A, Hayashi S, Teranishi Y, Imoto S, Nakamura H.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:45-53. doi: 10.1016/j.ejogrb.2016.12.006. Epub 2016 Dec 6.

PMID:
27940393
31.

Portomesenteric Vein Thrombosis After Excision of Parasitic Peritoneal Myomas.

Takeda A, Hayashi S, Teranishi Y, Imoto S, Nakamura H.

J Minim Invasive Gynecol. 2017 Mar - Apr;24(3):501-505. doi: 10.1016/j.jmig.2016.11.015. Epub 2016 Dec 7.

PMID:
27939898
32.

Bile duct adenoma in patient with chronic hepatitis C: As a benign neoplasm by pathological and imaging studies.

Kim SK, Kim SR, Imoto S, Kim CW, Matsuoka T, Nakashima O, Sasaki M, Kumabe T, Kudo M, Fukusato T, Kondo F.

Pathol Int. 2016 Nov;66(11):640-642. doi: 10.1111/pin.12457. Epub 2016 Sep 23. No abstract available.

PMID:
27663997
33.

Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.

Park H, Niida A, Imoto S, Miyano S.

J Comput Biol. 2017 Feb;24(2):138-152. doi: 10.1089/cmb.2016.0140. Epub 2016 Oct 19.

PMID:
27759426
34.

Gynandroblastoma with a Juvenile Granulosa Cell Component in an Adolescent: Case Report and Literature Review.

Takeda A, Watanabe K, Hayashi S, Imoto S, Nakamura H.

J Pediatr Adolesc Gynecol. 2017 Apr;30(2):251-255. doi: 10.1016/j.jpag.2016.10.005. Epub 2016 Oct 15. Review.

PMID:
27751908
35.

Coffee Intake and Liver Enzyme Association in Korean Immigrants and Japanese: A Comprehensive Cross-Sectional Study.

Kim SK, Shin MH, Sugimoto K, Kim SR, Imoto S, Kim KI, Taniguchi M, Oh HK, Yano Y, Hayashi Y, Kudo M.

Dig Dis. 2016;34(6):665-670. Epub 2016 Oct 17.

PMID:
27750235
36.

Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2.

Sugimoto K, Kim SK, Kim SR, Kobayashi M, Kato A, Morimoto E, Imoto S, Kim CW, Tanaka Y, Kudo M, Yano Y, Hayashi Y.

Dig Dis. 2016;34(6):627-631. Epub 2016 Oct 17.

PMID:
27750229
37.

Predicting Japanese Kampo formulas by analyzing database of medical records: a preliminary observational study.

Yoshino T, Katayama K, Horiba Y, Munakata K, Yamaguchi R, Imoto S, Miyano S, Mima H, Watanabe K.

BMC Med Inform Decis Mak. 2016 Sep 13;16:118. doi: 10.1186/s12911-016-0361-9.

38.

Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.

Imoto S, Yamauchi C, Komoike Y, Tsugawa K, Yotsumoto D, Wada N, Ueno T, Oba MS, Shien T, Sugae S, Tsuda H, Yoneyama K.

Breast Cancer. 2017 May;24(3):427-432. doi: 10.1007/s12282-016-0721-4. Epub 2016 Aug 23.

PMID:
27553957
39.

Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis.

Kim SK, Kim SR, Imoto S, Kim CW, Matsuoka T, Sasaki M, Nakashima O, Kumabe T, Hayashi Y.

Pathol Int. 2016 Sep;66(9):543-5. doi: 10.1111/pin.12435. Epub 2016 Jul 14. No abstract available.

PMID:
27418411
40.

Gasless single-port laparoscopic-assisted vaginal hysterectomy for large uteri weighing 500g or more.

Takeda A, Hayashi S, Imoto S, Nakamura H.

Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:239-44. doi: 10.1016/j.ejogrb.2016.06.006. Epub 2016 Jun 20.

PMID:
27352286
41.

Toward Extreme Biophysics: Deciphering the Infrared Response of Biomolecular Solutions at High Pressures.

Imoto S, Kibies P, Rosin C, Winter R, Kast SM, Marx D.

Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9534-8. doi: 10.1002/anie.201602757. Epub 2016 Jun 28.

PMID:
27351995
42.

Iron-chelating agent, deferasirox, inhibits neutrophil activation and extracellular trap formation.

Kono M, Saigo K, Yamamoto S, Shirai K, Iwamoto S, Uematsu T, Takahashi T, Imoto S, Hashimoto M, Minami Y, Wada A, Takenokuchi M, Kawano S.

Clin Exp Pharmacol Physiol. 2016 Oct;43(10):915-20. doi: 10.1111/1440-1681.12612.

PMID:
27333499
43.

Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer.

Tamura K, Hazama S, Yamaguchi R, Imoto S, Takenouchi H, Inoue Y, Kanekiyo S, Shindo Y, Miyano S, Nakamura Y, Kiyotani K.

Oncol Lett. 2016 Jun;11(6):3643-3649. Epub 2016 Apr 19.

44.

Reduced expression of APC-1B but not APC-1A by the deletion of promoter 1B is responsible for familial adenomatous polyposis.

Yamaguchi K, Nagayama S, Shimizu E, Komura M, Yamaguchi R, Shibuya T, Arai M, Hatakeyama S, Ikenoue T, Ueno M, Miyano S, Imoto S, Furukawa Y.

Sci Rep. 2016 May 24;6:26011. doi: 10.1038/srep26011.

45.

A Novel Adaptive Penalized Logistic Regression for Uncovering Biomarker Associated with Anti-Cancer Drug Sensitivity.

Park H, Shiraishi Y, Imoto S, Miyano S.

IEEE/ACM Trans Comput Biol Bioinform. 2017 Jul-Aug;14(4):771-782. doi: 10.1109/TCBB.2016.2561937. Epub 2016 May 3.

PMID:
27164605
46.

Abnormal Corneal Lesions Induced by Trastuzumab Emtansine: An Antibody-Drug Conjugate for Breast Cancer.

Tsuda M, Takano Y, Shigeyasu C, Imoto S, Yamada M.

Cornea. 2016 Oct;35(10):1378-80. doi: 10.1097/ICO.0000000000000868.

PMID:
27149538
47.

Characterization of T-cell Receptor Repertoire in Inflamed Tissues of Patients with Crohn's Disease Through Deep Sequencing.

Chapman CG, Yamaguchi R, Tamura K, Weidner J, Imoto S, Kwon J, Fang H, Yew PY, Marino SR, Miyano S, Nakamura Y, Kiyotani K.

Inflamm Bowel Dis. 2016 Jun;22(6):1275-85. doi: 10.1097/MIB.0000000000000752.

PMID:
27135481
48.

The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing.

Mao Y, Tamura T, Yuki Y, Abe D, Tamada Y, Imoto S, Tanaka H, Homma H, Tagawa K, Miyano S, Okazawa H.

Cell Death Dis. 2016 Apr 28;7:e2207. doi: 10.1038/cddis.2016.101.

49.

Design principles for high-pressure force fields: Aqueous TMAO solutions from ambient to kilobar pressures.

Hölzl C, Kibies P, Imoto S, Frach R, Suladze S, Winter R, Marx D, Horinek D, Kast SM.

J Chem Phys. 2016 Apr 14;144(14):144104. doi: 10.1063/1.4944991.

PMID:
27083705
50.

The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma.

Muramatsu T, Kozaki KI, Imoto S, Yamaguchi R, Tsuda H, Kawano T, Fujiwara N, Morishita M, Miyano S, Inazawa J.

Oncogene. 2016 Oct 6;35(40):5304-5316. doi: 10.1038/onc.2016.71. Epub 2016 Apr 4.

PMID:
27041563

Supplemental Content

Support Center